Legal Representation
Attorney
Steven E. Lauridsen
USPTO Deadlines
Application History
17 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 21, 2026 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Jul 7, 2025 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Jan 31, 2025 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Jan 31, 2025 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Jul 18, 2024 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Jul 18, 2024 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
| Jul 18, 2024 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Jun 27, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 26, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 26, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 27, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 27, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 27, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 26, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 22, 2024 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Sep 28, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 8, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Chemicals for use in biotechnological manufacturing processes; Chemicals for use in biotechnological product development; Chemical substances for use in the biotechnological industry; media for cell culture for research use in the biotechnological industry; Chemical reagents for use in biotechnology, other than for medical or veterinary use; all of the aforesaid being for use in cell therapy, living cell therapy and the treatment of cancer
Class 005
Pharmaceuticals for cell therapy and the treatment of cancer; biotechnological immune cell preparations for medical use; media for cell culture for medical use in the biotechnological industry; all of the aforesaid being for use in cell therapy, living cell therapy and the treatment of cancer
Class 042
Biotechnological research; Biotechnology research; Research relating to biotechnology; Biotechnological research relating to industry; Research and development in the field of biotechnology; Research and development in the pharmaceutical and biotechnology fields; Information on the subject of scientific research in the field of biochemistry and biotechnology; research and development relating to anti-cancer alpha neutrophils; all of the aforesaid relating to cell therapy, living cell therapy and the treatment of cancer
Classification
International Classes
001
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
BIOSCIENCES